HIGH LEVELS OF ERCC1 ARE ASSOCIATED WITH CISPLATIN RESISTANCE IN NEUROBLASTOMA

被引：0
|
作者：
Meret, Henry [1 ]
Wang, Zhihong [1 ]
Liu, Yimin [1 ]
机构：
[1] Childrens Hosp Michigan, Detroit, MI 48201 USA
来源：
PEDIATRIC BLOOD & CANCER | 2011年 / 57卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：784 / 784
页数：1
相关论文
共 50 条
  • [1] Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas
    Chen, Hua-Yun
    Shao, Cui-Jie
    Chen, Fu-Rong
    Kwan, Aij-Lie
    Chen, Zhong-Ping
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (08) : 1944 - 1954
  • [2] ROLE OF ERCC1 PROMOTER HYPERMETHYLATION IN DRUG RESISTANCE TO CISPLATIN IN HUMAN GLIOMAS
    Chen, H.
    Kwan, A.
    Chen, Z.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1147 - 1147
  • [3] ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
    Wang, Lifeng
    Wei, Jia
    Qian, Xiaoping
    Yin, Haitao
    Zhao, Yang
    Yu, Lixia
    Wang, Tingting
    Liu, Baorui
    BMC CANCER, 2008, 8 (1)
  • [4] ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
    Lifeng Wang
    Jia Wei
    Xiaoping Qian
    Haitao Yin
    Yang Zhao
    Lixia Yu
    Tingting Wang
    Baorui Liu
    BMC Cancer, 8
  • [5] Development of antibodies for detection of ERCC1 overexpression, a possible biomarker for cisplatin resistance of cancer
    Oishi, Takayuki
    Sasaki, Yuka
    Fujimori, Hiroaki
    Shibata, Noriko
    Iwasa, Satoru
    Nakao, Kazuhiko
    Yamada, Yasuhide
    Hiraoka, Nobuyoshi
    Masutani, Mitsuko
    CANCER SCIENCE, 2018, 109 : 1148 - 1148
  • [6] ERCC1 haplotypes are associated with melanoma
    Price, D. K.
    Gao, R.
    Sissung, T. M.
    Reece, K. M.
    Rosenberg, S. A.
    Figg, W. D.
    ANNALS OF ONCOLOGY, 2011, 22 : 26 - 26
  • [7] Establishment of monoclonal antibody to detect ERCC1 overexpression, a possible biomarker for cisplatin resistance
    Oishi, Takayuki
    Sasaki, Yuka
    Furusato, Bungo
    Iwasa, Satoru
    Nakao, Kazuhiko
    Yamada, Yasuhide
    Hiraoka, Nobuyoshi
    Masutani, Mitsuko
    CANCER SCIENCE, 2018, 109 : 603 - 603
  • [8] ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines
    Li, Wei
    Jie, ZhiGang
    Li, Zhengrong
    Liu, Yi
    Gan, Quan
    Mao, Yiqiu
    Wang, Xuemin
    MOLECULAR MEDICINE REPORTS, 2014, 9 (06) : 2423 - 2428
  • [9] Participation of ERCC1 in resistance against cisplatin for human esophageal cancer cell lines
    Miyahara, T
    Yanagihashi, K
    Kajiwara, T
    Akaboshi, M
    Kawabe, A
    Kaganoi, JI
    PROCEEDINGS OF THE 37TH CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, 2002, : 195 - 199
  • [10] ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells
    Britten, RA
    Liu, D
    Tessier, A
    Hutchison, MJ
    Murray, D
    INTERNATIONAL JOURNAL OF CANCER, 2000, 89 (05) : 453 - 457
12345